Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells

被引：42

作者：

Jia, Bin ^{[1
,2
,3
]}

Choy, Edwin ^{[1
,2
]}

Cote, Gregory ^{[1
,2
]}

Harmon, David ^{[1
,2
]}

Ye, Shunan ^{[1
,2
]}

Kan, Quancheng ^{[3
]}

Mankin, Henry ^{[1
,2
]}

Hornicek, Francis ^{[1
,2
]}

Duan, Zhenfeng ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharmacol, Zhengzhou 450052, Henan, Peoples R China

来源：

CANCER LETTERS | 2014年 / 342卷 / 01期

基金：

美国国家卫生研究院;

关键词：

Kinase; Liposarcoma; CDK11; Tissue microarray; Immunohistochemistry; ADVANCED SOLID TUMORS; SOFT-TISSUE SARCOMA; I CLINICAL-TRIAL; PHASE-I; DEDIFFERENTIATED LIPOSARCOMA; INHIBITOR FLAVOPIRIDOL; C-JUN; OSTEOSARCOMA; EXPRESSION; COMPLEXES;

D O I：

10.1016/j.canlet.2013.08.040

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Liposarcoma is the second most common soft tissue sarcoma in adults, but treatment options have been quite limited thus far. In this study, we investigated the functional and therapeutic relevance of cyclin-dependent kinase 11 (CDK11) as a putative target in liposarcoma. CDK11 knockdown by synthetic siRNA or lentiviral shRNA decreased cell proliferation, and induced apoptosis in liposarcoma cells. Moreover, CDK11 knockdown enhances the cytotoxic effect of doxorubicin to inhibit cell growth in liposarcoma cells. These findings suggest that CDK11 is critical for the growth and proliferation of liposarcoma cells. CDK11 may be a promising therapeutic target for the treatment of liposarcoma patients. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

下载

页码：104 / 112

页数：9

共 50 条

[41] Cyclin-Dependent Kinase 5 in Axon Growth and Regeneration
Ye, Tao
Fu, Amy K. Y.
Ip, Nancy Y.
AXON GROWTH AND REGENERATION, PT 1, 2012, 105 : 91 - +
[42] Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation
Duan, Zhenfeng
Zhang, Jianming
Choy, Edwin
Harmon, David
Liu, Xianzhe
Nielsen, Petur
Mankin, Henry
Gray, Nathanael S.
Hornicek, Francis J.
CLINICAL CANCER RESEARCH, 2012, 18 (17) : 4580 - 4588
[43] Cyclin-dependent kinase 5 (CDK5) and neuronal cell death
J. H. Weishaupt
C. Neusch
M. Bähr
Cell and Tissue Research, 2003, 312 : 1 - 8
[44] Perspective of Cyclin-dependent kinase 9 (CDK9) as a Drug Target
Krystof, Vladimir
Baumli, Sonja
Fuerst, Robert
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (20) : 2883 - 2890
[45] Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease
Alrouji, Mohammed
Al-kuraishy, Haydar M.
Al-Gareeb, Ali I.
Alshammari, Mohammed S.
Alexiou, Athanasios
Papadakis, Marios
Bahaa, Mostafa M.
Batiha, Gaber El-Saber
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (11)
[46] The cyclin-dependent kinase Cdk1 directly regulates vacuole inheritance
Peng, Yutian
Weisman, Lois S.
DEVELOPMENTAL CELL, 2008, 15 (03) : 478 - 485
[47] Cyclin-dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials
Panagiotou, E.
Gomatou, G.
Trontzas, I. P.
Syrigos, N.
Kotteas, E.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (02): : 161 - 192
[48] The overexpression of cyclin-dependent kinase (CDK) 2 in laryngeal squamous cell carcinomas
Dong, YY
Sui, L
Tai, YJ
Sugimoto, K
Tokuda, M
ANTICANCER RESEARCH, 2001, 21 (1A) : 103 - 108
[49] Cdk(cyclin-dependent kinase) is required for genomic union in the fertilized starfish eggs
Tachibana, Kazunori
Hattori, Yukako
Kishimoto, Takeo
ZOOLOGICAL SCIENCE, 2005, 22 (12) : 1457 - 1457
[50] Cyclin-dependent kinase 5 (CDK5) regulates the circadian clock
Brenna, Andrea
Olejniczak, Iwona
Chavan, Rohit
Ripperger, Jurgen A.
Langmesser, Sonja
Cameroni, Elisabetta
Hu, Zehan
De Virgilio, Claudio
Dengjel, Jorn
Albrecht, Urs
ELIFE, 2019, 8

← 1 2 3 4 5 →